Silvia Lucano‐Landeros

589 total citations
13 papers, 458 citations indexed

About

Silvia Lucano‐Landeros is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Silvia Lucano‐Landeros has authored 13 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hepatology, 4 papers in Epidemiology and 3 papers in Molecular Biology. Recurrent topics in Silvia Lucano‐Landeros's work include Liver physiology and pathology (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Silvia Lucano‐Landeros is often cited by papers focused on Liver physiology and pathology (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Silvia Lucano‐Landeros collaborates with scholars based in Mexico. Silvia Lucano‐Landeros's co-authors include Juan Armendáriz‐Borunda, Arturo Santos, Marina Galicia‐Moreno, Hugo Christian Monroy-Ramírez, Jorge Gutiérrez‐Cuevas, Ana Sandoval-Rodríguez, Sergio Sánchez‐Enríquez, José Macías‐Barragán, Margarita Montoya‐Buelna and José Navarro‐Partida and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Molecules.

In The Last Decade

Silvia Lucano‐Landeros

12 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silvia Lucano‐Landeros Mexico 9 135 135 98 95 56 13 458
Jesús García‐Bañuelos Mexico 14 157 1.2× 175 1.3× 106 1.1× 28 0.3× 70 1.3× 28 544
Theerut Luangmonkong Thailand 12 223 1.7× 235 1.7× 225 2.3× 51 0.5× 98 1.8× 17 643
Rebecca L. McCullough United States 14 226 1.7× 249 1.8× 76 0.8× 57 0.6× 64 1.1× 33 605
Lukas Geisler Germany 9 216 1.6× 249 1.8× 144 1.5× 30 0.3× 97 1.7× 17 535
Christian Freise Germany 17 199 1.5× 69 0.5× 32 0.3× 61 0.6× 81 1.4× 34 622
Chia-Yun Lai Taiwan 13 101 0.7× 187 1.4× 128 1.3× 16 0.2× 145 2.6× 35 544
Yung-Tsung Chiu Taiwan 12 133 1.0× 139 1.0× 143 1.5× 37 0.4× 80 1.4× 20 447
Kwangsik Chun South Korea 9 106 0.8× 161 1.2× 90 0.9× 103 1.1× 123 2.2× 18 478
Yoichiro Takami Japan 13 178 1.3× 65 0.5× 56 0.6× 35 0.4× 39 0.7× 25 385

Countries citing papers authored by Silvia Lucano‐Landeros

Since Specialization
Citations

This map shows the geographic impact of Silvia Lucano‐Landeros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Lucano‐Landeros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Lucano‐Landeros more than expected).

Fields of papers citing papers by Silvia Lucano‐Landeros

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Lucano‐Landeros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Lucano‐Landeros. The network helps show where Silvia Lucano‐Landeros may publish in the future.

Co-authorship network of co-authors of Silvia Lucano‐Landeros

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Lucano‐Landeros. A scholar is included among the top collaborators of Silvia Lucano‐Landeros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Lucano‐Landeros. Silvia Lucano‐Landeros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
García‐Bañuelos, Jesús, Ana Sandoval-Rodríguez, Blanca Estela Bastidas‐Ramírez, et al.. (2023). AdhMMP8 Vector Administration in Muscle: An Alternate Strategy to Regress Hepatic Fibrosis. Cells. 12(17). 2127–2127.
2.
Sandoval-Rodríguez, Ana, Marina Galicia‐Moreno, Silvia Lucano‐Landeros, et al.. (2023). Pirfenidone Protects from UVB-Induced Photodamage in Hairless Mice. Molecules. 28(7). 2929–2929. 7 indexed citations
3.
Gutiérrez‐Cuevas, Jorge, et al.. (2022). Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies. Cancers. 15(1). 23–23. 38 indexed citations
4.
Galicia‐Moreno, Marina, Ana Sandoval-Rodríguez, Silvia Lucano‐Landeros, et al.. (2021). Hepatocarcinogenesis Prevention by Pirfenidone Is PPARγ Mediated and Involves Modification of Nuclear NF-kB p65/p50 Ratio. International Journal of Molecular Sciences. 22(21). 11360–11360. 21 indexed citations
5.
Galicia‐Moreno, Marina, et al.. (2021). Liver Cancer: Therapeutic Challenges and the Importance of Experimental Models. Canadian Journal of Gastroenterology and Hepatology. 2021(1). 8837811–8837811. 36 indexed citations
6.
Galicia‐Moreno, Marina, Silvia Lucano‐Landeros, Hugo Christian Monroy-Ramírez, et al.. (2020). Roles of Nrf2 in Liver Diseases: Molecular, Pharmacological, and Epigenetic Aspects. Antioxidants. 9(10). 980–980. 92 indexed citations
7.
Meza-Ríos, Alejandra, Silvia Lucano‐Landeros, Ana Sandoval-Rodríguez, et al.. (2020). Evaluation of Safety of a Newly Formulated Pirfenidone in Chronic Kidney Disease: A Non-Randomized Pilot Study in Mexican Patients. SHILAP Revista de lepidopterología. 4(1). 22–30. 1 indexed citations
8.
Lucano‐Landeros, Silvia, Adriana María Salazar-Montes, Ana Sandoval-Rodríguez, et al.. (2017). Pirfenidone Accelerates Wound Healing in Chronic Diabetic Foot Ulcers: A Randomized, Double-Blind Controlled Trial. Journal of Diabetes Research. 2017. 1–12. 25 indexed citations
9.
Montoya‐Buelna, Margarita, et al.. (2015). Role and New Insights of Pirfenidone in Fibrotic Diseases. International Journal of Medical Sciences. 12(11). 840–847. 114 indexed citations
10.
Sandoval-Rodríguez, Ana, et al.. (2014). Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C. BMC Gastroenterology. 14(1). 131–131. 67 indexed citations
11.
Cárdenas-Camarena, Lázaro, et al.. (2011). Controlled Clinical Trial With Pirfenidone in the Treatment of Breast Capsular Contracture. Annals of Plastic Surgery. 70(1). 16–22. 30 indexed citations
12.
García‐Bañuelos, Jesús, Carlos Beas‐Zárate, V. Chaparro‐Huerta, et al.. (2010). Combinatorial gene therapy induces regression of hepatic encephalopathy. Gene Therapy. 18(1). 88–94. 8 indexed citations
13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jesús García‐Bañuelos Breakdown of academic impact, for papers by Theerut Luangmonkong Breakdown of academic impact, for papers by Rebecca L. McCullough Breakdown of academic impact, for papers by Lukas Geisler Breakdown of academic impact, for papers by Christian Freise Breakdown of academic impact, for papers by Chia-Yun Lai Breakdown of academic impact, for papers by Yung-Tsung Chiu Breakdown of academic impact, for papers by Kwangsik Chun Breakdown of academic impact, for papers by Yoichiro Takami
Rankless by CCL
2026